Galapagos reported -76332000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
AstraZeneca AZN:LN 539M 339M
Biogen BIIB:US $ -59.1M 669.8M
Genmab GEN:DC 514M 295M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 1.08B 1.72B
Hikma Pharmaceutical HIK:LN 249M 6M
Merck MRK:GR € 1177M 4M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Novartis NOVN:VX 2.23B 624M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
YTE INCY:US $ 254.43M 137.89M